Ophiopogonin D′ Targets PPM1B to Suppress B-Cell Acute Lymphoblastic Leukemia via Disruption of Wnt/β-Catenin Signaling
- 1Shandong First Medical University and Shandong Academy of Medical Sciences , , ,
- 2Jining Medical University , , , ,
Abstract
B-cell acute lymphoblastic leukemia (B-ALL) carries a dismal prognosis in adults due to the scarcity of effective targeted therapies, underscoring an urgent need for novel agents. Ophiopogonin D′ (OPD′), a steroidal saponin structurally distinct from Ophiopogonin D (differing in aglycone and glycosylation), is isolated from Ophiopogon japonicus. While OPD has been studied in solid tumors, the potential of OPD′ in hematological malignancies remains completely unexplored. Here, we identify OPD′ as a potent and selective agent against B-ALL. OPD′ suppresses B-ALL cell proliferation, induces G0/G1 arrest and apoptosis, and markedly inhibits xenograft tumor growth in vivo without overt toxicity. Using Cellular Thermal Shift Assay coupled with Mass Spectrometry (CETSA-MS), we discover that protein phosphatase magnesium/manganese-dependent 1B (PPM1B) is the direct cellular target of OPD′. Mechanistically, OPD′ acts as a competitive inhibitor of PPM1B phosphatase activity, with mutational mapping identifying Arg-33 and Glu-35 as critical binding residues. Global phosphoproteomics reveals that OPD′-mediated PPM1B inhibition disrupts Wnt/β-catenin signaling by elevating β-catenin phosphorylation at Ser37, leading to the downregulation of c-Myc and Cyclin D1, upregulation of p27, and a pro-apoptotic Bax/Bcl-2 imbalance. Genetic knockdown of PPM1B phenocopies OPD′-induced cytotoxicity, while PPM1B depletion attenuates OPD′’s antileukemic effects, confirming on-target specificity. Collectively, this study establishes OPD′ as a natural PPM1B inhibitor and unveils PPM1B as a novel druggable vulnerability in B-ALL, providing a promising therapeutic lead for clinical translation.
Related
- High-dose cerium dioxide nanorods induce behavioral and electroencephalographic abnormalities through 5-HT1B receptor signaling disruption with an evaluation of anpirtoline's therapeutic potential.
- Surface adsorbates suppress low-frequency noise for shallow nitrogen-vacancy centers
- Al-doped C3N4 composite cathodes suppress polysulfide shuttle and enable long-lifetime Li-S batteries with physics-informed NeuralODE lifetime forecasting
- Stable Phosphonate Inhibitors of Elastase LasB Suppress Pseudomonas aeruginosa Virulence via Zinc-Targeting Pyrrolidone Scaffolds
- Mesoscale hydrogen-bond network engineering controls quantum-coherent proton transport to suppress aluminum corrosion
BibTeX
@article{liu2026ophiopogonin,
title = {{Ophiopogonin D′ Targets PPM1B to Suppress B-Cell Acute Lymphoblastic Leukemia via Disruption of Wnt/β-Catenin Signaling}},
author = {Teng Liu and Jiayu Liu and Bowen Liu and Runqing Gong and Xiaohui Tang and Zhi-Yuan Lu},
journal = {ACS Omega},
year = {2026},
month = oct,
doi = {10.1021/acsomega.6c08498},
url = {https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c08498/5461074/Ophiopogonin-D-Targets-PPM1B-to-Suppress-B-Cell},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Ophiopogonin D′ Targets PPM1B to Suppress B-Cell Acute Lymphoblastic Leukemia via Disruption of Wnt/β-Catenin Signaling
AU - Teng Liu
AU - Jiayu Liu
AU - Bowen Liu
AU - Runqing Gong
AU - Xiaohui Tang
AU - Zhi-Yuan Lu
PY - 2026
DA - 2026/10/29
JO - ACS Omega
DO - 10.1021/acsomega.6c08498
UR - https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c08498/5461074/Ophiopogonin-D-Targets-PPM1B-to-Suppress-B-Cell
AB - B-cell acute lymphoblastic leukemia (B-ALL) carries a dismal prognosis in adults due to the scarcity of effective targeted therapies, underscoring an urgent need for novel agents. Ophiopogonin D′ (OPD′), a steroidal saponin structurally distinct from Ophiopogonin D (differing in aglycone and glycosylation), is isolated from Ophiopogon japonicus. While OPD has been studied in solid tumors, the potential of OPD′ in hematological malignancies remains completely unexplored. Here, we identify OPD′ as a potent and selective agent against B-ALL. OPD′ suppresses B-ALL cell proliferation, induces G0/G1 arrest and apoptosis, and markedly inhibits xenograft tumor growth in vivo without overt toxicity. Using Cellular Thermal Shift Assay coupled with Mass Spectrometry (CETSA-MS), we discover that protein phosphatase magnesium/manganese-dependent 1B (PPM1B) is the direct cellular target of OPD′. Mechanistically, OPD′ acts as a competitive inhibitor of PPM1B phosphatase activity, with mutational mapping identifying Arg-33 and Glu-35 as critical binding residues. Global phosphoproteomics reveals that OPD′-mediated PPM1B inhibition disrupts Wnt/β-catenin signaling by elevating β-catenin phosphorylation at Ser37, leading to the downregulation of c-Myc and Cyclin D1, upregulation of p27, and a pro-apoptotic Bax/Bcl-2 imbalance. Genetic knockdown of PPM1B phenocopies OPD′-induced cytotoxicity, while PPM1B depletion attenuates OPD′’s antileukemic effects, confirming on-target specificity. Collectively, this study establishes OPD′ as a natural PPM1B inhibitor and unveils PPM1B as a novel druggable vulnerability in B-ALL, providing a promising therapeutic lead for clinical translation.
SN - 2470-1343
ER -